NCT04905407 2025-02-24Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)Syros PharmaceuticalsPhase 2 Terminated66 enrolled 21 charts